Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Rhinoplasty
NCT05774717Phase 1Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2023
- Primary completion
- Apr 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of tranexamic acid in hemorrhage (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Intraoperative bleeding as measured by the weight of surgical sponges used, Intraoperative bleeding as measured by the volume of blood in suction canister and 4 more. Started Apr 2023; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05774717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05774717.